{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:10:17Z","timestamp":1791141017553,"version":"4.1.0"},"reference-count":20,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The diagnosis of type 1 von Willebrand disease (VWD) is based on the presence of bleeding symptoms, reduced von Willebrand factor (VWF) levels, and autosomal inheritance of the phenotype. To better appreciate the contribution of clinical and laboratory data to the final diagnosis of VWD, we computed the likelihoods of having VWD as a function of the bleeding score (LRscore), of VWF level (LRVWF), and of number of first-degree family members with reduced VWF levels (LRfamily). The 3 likelihoods were therefore combined using the Bayes theorem, giving the final probability (odds) of having VWD. LRfamily and LRVWF were the 2 factors mostly influencing the final probability of having VWD. Data from the present study provide an evidence-based description of the minimal criteria for the diagnosis of type 1 VWD. As an example, presence of VWF levels lower than 40 IU\/dL in at least 2 family members (including the proband) and a bleeding score of at least 1 were found to be required for a final odd of VWD higher than 2.0 (false-positive rate less than one-half). Validation of this approach and of its clinical utility is, however, required by analysis in other cohorts of well-characterized type 1 VWD patients.<\/jats:p>","DOI":"10.1182\/blood-2007-08-105940","type":"journal-article","created":{"date-parts":[[2008,1,10]],"date-time":"2008-01-10T20:59:21Z","timestamp":1199998761000},"page":"3998-4003","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":65,"title":["Evidence-based diagnosis of type 1 von Willebrand disease: a Bayes theorem approach"],"prefix":"10.1182","volume":"111","author":[{"given":"Alberto","family":"Tosetto","sequence":"first","affiliation":[{"name":"Hematology Department, San Bortolo Hospital, Vicenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Castaman","sequence":"additional","affiliation":[{"name":"Hematology Department, San Bortolo Hospital, Vicenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Rodeghiero","sequence":"additional","affiliation":[{"name":"Hematology Department, San Bortolo Hospital, Vicenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111714562819400_B1","first-page":"377","article-title":"Prevalence of von Willebrand's disease among U.S. adults.","volume":"78","author":"Miller","year":"1987","journal-title":"Blood"},{"key":"2019111714562819400_B2","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand's disease.","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"key":"2019111714562819400_B3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/9780470988633.ch6","article-title":"von Willebrand disease.","volume-title":"Practical Hemostasis and Thrombosis","author":"Castaman","year":"2005"},{"key":"2019111714562819400_B4","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor.","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"2019111714562819400_B5","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1111\/j.1538-7836.2004.00933.x","article-title":"Slippery criteria for von Willebrand disease type 1.","volume":"2","author":"Sadler","year":"2004","journal-title":"J Thromb Haemost"},{"key":"2019111714562819400_B6","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1538-7836.2005.01245.x","article-title":"Provisional criteria for the diagnosis of VWD type 1; on behalf of the SSC Subcommittee on von Willebrand factor.","volume":"3","author":"Sadler","year":"2005","journal-title":"J Thromb Haemost"},{"key":"2019111714562819400_B7","article-title":"Clinical Epidemiology: A Basic Science for Clinical Medicine.","author":"Sackett","year":"1991","edition":"1st ed."},{"key":"2019111714562819400_B8","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/j.1538-7836.2005.01663.x","article-title":"The discriminant power of bleeding history for the diagnosis of von Willebrand disease type 1: an international, multicenter study.","volume":"3","author":"Rodeghiero","year":"2005","journal-title":"J Thromb Haemost"},{"key":"2019111714562819400_B9","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1538-7836.2006.01847.x","article-title":"A quantitative analysys of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD).","volume":"4","author":"Tosetto","year":"2006","journal-title":"J Thromb Haemost"},{"key":"2019111714562819400_B10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with Type 1 von Willebrand Disease in the European study, molecular and clinical markers for the diagnosis and management of Type 1 von Willebrand disease (MCMDM-1VWD).","volume":"109","author":"Goodeve","year":"2007","journal-title":"Blood"},{"key":"2019111714562819400_B11","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/clinchem\/28.5.1113","article-title":"On the use and computation of likelihood ratios in clinical chemistry.","volume":"28","author":"Albert","year":"1982","journal-title":"Clin Chem"},{"key":"2019111714562819400_B12","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/s-0037-1613992","article-title":"Impact, diagnosis and treatment of von Willebrand disease.","volume":"84","author":"Sadler","year":"2000","journal-title":"Thromb Haemost"},{"key":"2019111714562819400_B13","unstructured":"Rodeghiero F Castaman G Tosetto A Bleeding score and bleeding questionnaire for the diagnosis of type 1 von Willebrand disease. Accessed January 10, 2008 http:\/\/www.med.unc.edu\/isth\/ssc\/collaboration\/Bleeding_Type1_VWD.pdf"},{"key":"2019111714562819400_B14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.blre.2006.04.002","article-title":"Assessing bleeding in von Willebrand disease with bleeding score.","volume":"21","author":"Tosetto","year":"2007","journal-title":"Blood Rev"},{"key":"2019111714562819400_B15","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198509844.001.0001","article-title":"The statistical evaluation of medical tests for classification and prediction.","author":"Pepe","year":"2003"},{"key":"2019111714562819400_B16","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1538-7836.2007.02444.x","article-title":"Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD).","volume":"5","author":"Tosetto","year":"2007","journal-title":"J Thromb Haemost"},{"key":"2019111714562819400_B17","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9781139167987","article-title":"Genetic variation and human disease.","author":"Weiss","year":"1993"},{"key":"2019111714562819400_B18","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1182\/blood-2002-09-2892","article-title":"Von Willebrand disease type 1: a diagnosis in search of a disease.","volume":"101","author":"Sadler","year":"2003","journal-title":"Blood"},{"key":"2019111714562819400_B19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1053\/beha.2001.0136","article-title":"Congenital von Willebrand disease type I: definition, phenotypes, clinical and laboratory assessment.","volume":"14","author":"Rodeghiero","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"2019111714562819400_B20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-0038-1647316","article-title":"von Willebrand factor antigen is less sensitive than ristocetin cofactor for the diagnosis of type I von Willebrand disease: results based on an epidemiological investigation.","volume":"64","author":"Rodeghiero","year":"1990","journal-title":"Thromb Haemosta"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/111\/8\/3998\/1301225\/zh800808003998.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/111\/8\/3998\/1301225\/zh800808003998.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:02:47Z","timestamp":1708473767000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/111\/8\/3998\/24617\/Evidencebased-diagnosis-of-type-1-von-Willebrand"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,15]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,4,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2007-08-105940","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,15]]}}}